insights_auto
Why is ALC up 6.82%?
Dive Deeperchevron_right
ALC:NYSE
Alcon AG
$77.31
arrow_upward
+6.82%(+4.93) 1D
$77.20
arrow_downward
-0.14% (-0.11)bedtimeAfter hours
Closed: Nov 4, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$75.70
High
$77.85
Low
$75.58
Mkt. cap
31.71B
Avg. vol.
1.71M
Volume
3.75M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$75.70
High
$77.85
Low
$75.58
Mkt. cap
31.71B
Avg. vol.
1.71M
Volume
3.75M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
Yahoo Finance
·
7 hours ago
Alcon Inc. (ALC) Is Positioned to Benefit From Long-Term Healthcare Demand: Here’s the Investment Case
Yahoo Finance
·
1 day ago
Alcon Inc. (ALC) Stock Forecasts
Investing.com
·
2 days ago
Needham reiterates Alcon stock rating on Neurotech acquisition
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Industry-
Websitealcon.com